Spyre Therapeutics CFO Scott L. Burrows disposes of USD 1.85 million in common shares

Bitget2026/10/03 01:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Spyre Therapeutics CFO Scott L. Burrows cut his direct stake to 79,762 common shares.
Sold 17,500 shares on Sep. 30 at a weighted average price of $89.89.
Disposed of 7,500 shares on Oct. 1, including sales at weighted average prices from $89.07 to $93.57.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyre Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001636282-26-000117), on October 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Spyre Therapeutics CFO Scott L. Burrows disposes of USD 1.85 million in common shares

You may also like

Crypto prices